This conversation with startle you, infuriate you—then lift your spirits
It’s not every day an active HHS Secretary sits down for 90 minutes straight with Tucker Carlson.
But that’s exactly what happened, and Kennedy instantly seized Carlson’s attention with a chilling story of CDC corruption.
He revealed that the health agency buried a 1999 internal study led by researcher Thomas Verstraten, which showed an alarming 1135% increase in autism risk from the hepatitis B vaccine.
Kennedy said the researchers were “shocked” by the findings.
So what did they do? They covered it up, according to Kennedy.
“They got rid of all the older children essentially and just had younger children who are too young to be diagnosed [with autism].”
RFK Jr. then explained the real reason why your pediatrician will kick you out of their practice for refusing vaccines.
“There’s a published article out there now that says that 50% of revenues to most pediatricians come from vaccines.”
It’s all about the money. The higher the vaccination rate, the bigger the bonus.
“And that’s why your pediatrician, if you say I want to go slow on the vaccines… will throw you out of his practice because you’re now jeopardizing that bonus structure.”
—
To the claim that the vaccine–autism link has been “debunked,” Kennedy had a message for Anderson Cooper, Jake Tapper, and everyone who smugly insists on it.
“None of the vaccines given to children in the first six months of life have ever been studied for autism.”
Let that sink in.
He went further, revealing that the CDC actually did find a link when they studied the DTaP vaccine.
But they dismissed it. Kennedy said they claimed it “didn’t count” because the data came from VAERS—the very system they use to track vaccine injuries.
So when the evidence pointed to harm, they simply claimed their own system wasn’t reliable enough and took no steps to fix it.
—
The vaccine corruption didn’t end there. Kennedy attested that the CDC killed off a vaccine injury reporting system that actually worked—because it worked too well.
So what did the CDC do? They shut it down in 2010. And they’re still using VAERS today—even though it’s a completely inadequate system.
But Kennedy didn’t stop at old vaccine scandals. He also broke down Pfizer’s own COVID vaccine trial data. That trial showed a 23% higher death rate in the vaccinated group.
• Pfizer gave 21,720 people the vaccine and 21,728 the placebo.
• One vaccinated person died of COVID. Two placebo recipients died. They used this tiny difference to claim “100% effective” based on relative risk reduction.
• But in absolute terms, it took 22,000 vaccinations to save one life.
• Over six months, 21 vaccinated participants died of all causes, compared to 17 in the placebo group—a 23.5% higher death rate.
—
And then there’s vaccine spokesperson Paul Offit, often seen on CNN and other mainstream networks.
Kennedy shared an infuriating story about how he literally “voted himself rich” on the rotavirus vaccine.
While serving on the CDC’s ACIP committee, Offit voted to add rotavirus vaccination to the childhood schedule—even as he was developing his own competing vaccine. He guaranteed demand for his product.
The first approved rotavirus vaccine, RotaShield, was yanked from the market for causing dangerous intussusception. Offit’s vaccine, RotaTeq, eventually replaced it.
He and his partners later sold their rights to Merck for $186 million. As RFK Jr. said, Offit literally “voted himself rich.”
—
When Carlson mentioned Fauci, Kennedy revealed how Fauci funded research that helped scientists hide evidence of lab-made viruses.
The technique, called “seamless ligation,” allowed researchers to engineer viruses in a lab without leaving telltale genetic fingerprints.
RFK Jr. explained:
“One of his fundees, Ralph Baric, from the University of North Carolina, developed a technique called the seamless ligation technique, which is a technique for hiding the laboratory origins of a manipulated virus.”
“… normally if there’s a virus manipulated, researchers can look at the DNA sequences and they can say this thing was created in a lab. Ralph Baric had developed a technique that he called the no-see technique and its technical name was seamless ligation, and it was a way of hiding evidence of human tampering.”
He called it the exact opposite of what real public health work should be. Carlson cut in, saying, “That’s what you would do if you’re creating viruses for biological warfare.”
—
The conversation shifted to Trump, leading to one of the biggest highlights of the entire interview.
First, Kennedy explained that Trump chose his cabinet in an unorthodox way: he wanted to see three clips of each candidate performing on TV before considering them for the job.
“One of the things with President Trump is that he really knows how to pick talent… For every one of the positions that he picked, he wanted to see three clips of them performing on TV. He’s very conscious of the fact that these people are going to be out selling his program to the public,” Kennedy said.
—
That’s when Kennedy ended the interview with a bang, sharing his genuine thoughts about Trump for three straight minutes. It was one of the standout moments of the entire conversation.
If you’re on the fence about Trump, listen to Kennedy here. It might just change how you see him.
“I had him pegged as a narcissist, when narcissists are incapable of empathy. And he’s one of the most empathetic people that I’ve met,” Kennedy said.
“He’s immensely curious, inquisitive, and immensely knowledgeable. He’s encyclopedic in certain areas that you wouldn’t expect,” he continued.
Kennedy added that Trump genuinely cares about soldiers who go to war, citing how Trump “always talks about the casualties on both sides” of the Russia–Ukraine conflict.
“Whether it’s vaccines or Medicaid or Medicare, he’s always thinking about how this impacts the little guy. And the Democrats have him pegged as a guy who’s sort of sitting in the Cabinet meeting talking about how can we make billionaires richer. He’s the opposite of that. He’s a genuine populist,” Kennedy said.
There’s so much more in this conversation, and it might change the way you think about vaccines forever.
Todayville is a digital media and technology company. We profile unique stories and events in our community. Register and promote your community event for free.
The FDA old guard criticized the new leadership in a Dec. 3 New England Journal of Medicine (NEJM) letter over a higher regulatory bar for vaccines, namely the expectation that most new vaccine approvals will require randomized clinical trials, arguing it could hamper the market.
“Insisting on long, expensive outcomes studies for every updated formulation would delay the arrival of better-matched vaccines when new outbreaks emerge or when additional groups of patients could benefit,” the former commissioners wrote. “Abandoning the existing methods won’t ‘elevate vaccine science’ … It will subject vaccines to a substantially higher and more subjective approval bar.”
But while the former commissioners disclosed their conflicts of interest to the medical journal — per standard practice in scientific publishing — reporters didn’t relay them to the broader public in reports in the Washington Post, STAT News and CNN.
The headlines about a bipartisan rebuke from former occupants of FDA’s highest office give the impression that the Trump administration is contravening established science, but closer inspection reveals a revolving door between pharmaceutical corporations and the agencies overseeing them.
Three of the signatories have received payments totaling $6 million from manufacturers or former manufacturers of COVID vaccines.
Scott Gottlieb has received $2.1 million in cash and stock from his position on the Pfizer board of directors, where he has advised on ethics and regulatory compliance since 2019, according to company filings to the Securities and Exchange Commission. Stephen Ostroff has received $752,310 from Pfizer in consulting fees since 2020, according to OpenPayments.
Gottlieb and McClellan did not respond to requests for comment. Ostroff could not be reached for comment.
FDA Center for Biologics Evaluation and Research Director Vinay Prasad outlined the higher standards and shared the results of an internal analysis validating 10 reports of children’s deaths following the COVID-19 vaccine in a Nov. 28 memo to staff. He called for introspection and reform at the agency.
The NEJM letter criticizes Prasad for cracking down on a practice called “immunobridging” that infers vaccine efficacy from laboratory tests rather than assessing it through real-world reductions in disease or death. The FDA under the Biden administration expanded COVID vaccines to children using this “immunobridging” technique, extrapolating vaccine efficacy from adults to children based on antibody levels.
Norman Sharpless — who in addition to previously serving as acting FDA commissioner also served as the head of the National Institutes of Health’s National Cancer Institute — consults for Tempus, a company that collaborates with COVID vaccine maker BioNTech. He has helped steer $70 million in investments in biotech through a venture capital firm he founded in November 2024. Sharpless also disclosed $26,180 in payments in 2024 from Chugai Pharmaceutical, a Japanese pharmaceutical company that markets mRNA technology among other drugs, on OpenPayments.
“I was grateful for the opportunity to serve as NCI Director and Acting FDA Commissioner in the first Trump Administration, and strongly support many of the things President Trump is trying to do in the current Administration,” Sharpless said in an email.
Margaret Hamburg, another former FDA commissioner and signatory of the NEJM letter, has since 2020 earned $2.8 million as a member of the board of Alnylam Pharmaceuticals, which markets RNA interference (RNAi) technology.
Hamburg did not respond to a message on LinkedIn.
Most signatories disclosed income from biotech companies testing experimental cancer treatments. These products could face tighter scrutiny under Prasad, a hematologist-oncologist long wary of rubberstamping pricey oncology drugs — which Prasad points out often cause some toxicity — without plausible evidence of an improvement in quality of life or survival.
The former FDA commissioners disclosed ties to Sermonix Pharmaceuticals Inc.; OncoNano Medicine; incyclix; Nucleus Radiopharma; and N-Power, a contractor that runs oncology clinical trials.
Andrew von Eschenbach, who like Sharpless formerly served both as FDA commissioner and the head of the National Cancer Institute, disclosed stock in HistoSonics, a company with investments from Bezos Expeditions and Thiel Bio seeking FDA approval for ultrasound technology targeted at tumors.
Some FDA commissioners who signed onto the letter opposing changes to vaccine approvals have ties to biotechnology investment firms, namely McClellan, who consults Arsenal Capital; Janet Woodcock, who consults RA Capital Management; and Robert Califf, who owns stock in Population Health Partners.
Califf did not respond to an email requesting comment. Woodcock did not respond to requests for comment sent to two medical research advocacy groups with Woodcock on the board. Eschenbach did not respond to a LinkedIn message.
The two signatories without pharmaceutical ties may find their judgement challenged by the FDA investigation into COVID-19 vaccine deaths, having either implemented or formally defended the Biden administration’s headlong expansion of vaccines and boosters to healthy adults and children.
David Kessler executed Biden’s vaccination policy as chief science officer at the Department of Health and Human Services, helping to secure deals for shotswith Pfizer and Moderna.
Meanwhile Jane Henney chaired a National Academies of Sciences, Engineering, and Medicine report published in October 2025 that praised the performance of FDA and Centers for Disease Control and Prevention (CDC) vaccine surveillance during the pandemic — underwritten with CDC funding.
That assessment clashes with that of a Senate report, citing internal documents from FDA, finding that CDC never updated its vaccine surveillance tool “V-Safe” to include cardiac symptoms, despite naming myocarditis as a potential adverse event by October 2020, and that top officials in the Biden administration delayed warning pediatricians and other providers about the risk of myocarditis after their approval in some children in May 2021, months after Israeli health officials first detected it in February 2021. The Senate investigation named Woodcock, a signatory of the NEJM letter, as one of the FDA officials who slow-walked the warning.
HHS is also working to “reverse the Biden administration’s attempt” to classify gender dysphoria as a type of disability.
The U.S. Department of Health and Human Services unveiled a multi-pronged regulatory effort Thursday to curtail gender-affirming care for minors, including gender transition procedures at hospitals.
The Centers for Medicare & Medicaid Services has drafted a rule that would prohibit pharmaceutical or surgical gender reassignment procedures from receiving federal Medicaid or Children’s Health Insurance Program funding. It’s also proposing a rule that would allow it to withdraw Medicare and Medicaid funding from hospitals that perform such surgeries on minors. HHS is also working to “reverse the Biden administration’s attempt” to classify gender dysphoria as a type of disability. If gender dysphoria were to be defined as a disability, then health care providers who don’t want to perform what the department has dubbed “sex-rejecting” procedures could be in danger of violating anti-discrimination laws.
Health and Human Services Secretary Robert Kennedy, Jr., described gender affirming procedures as “unsafe” and “irreversible,” and framed the administration’s actions as “[protecting] America’s most vulnerable.”
“Our children deserve better – and we are delivering on that promise,” Kennedy told reporters Thursday.
The department is acting on directives from an executive order from President Donald Trump’s first few weeks in office. The Jan. 28 order called on government agencies to “[defund] chemical and surgical mutilation” of children, seemingly in the manner that HHS has proposed, as well as “rescind or amend all policies” relying on guidance from the World Professional Association for Transgender Health.
The Food and Drug Administration is also taking regulatory action against some organizations that market breast binders to minors.
“Illegal marketing of these products for children is alarming, and the FDA will take further enforcement action such as import alerts, seizures, and injunctions if it continues,” said Food and Drug Commissioner Marty Makary.
Kennedy signed a declaration Thursday that gender affirming procedures for minors “do not meet professionally recognized standards of health care” and the Assistant Secretary for Health and Head of the United States Public Health Service Commissioned Corps, Admiral Brian Christine, signed a public health message stating the same.
“Evidence shows sex-rejecting puberty blockers, cross-sex hormones, and surgeries are dangerous. Providers have an obligation to offer care grounded in evidence and to avoid interventions that expose young people to a lifetime of harm,” Christine said.
The House of Representatives passed a bill Wednesday that would criminalize the act of providing gender affirming care to minors.
